We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

What New Bulk Substance Rules Mean For The Drug Industry

Law360, New York (March 28, 2017, 4:48 PM EDT) -- The spotlight on compounding pharmacy safety shows no signs of fading following a 2012 fungal meningitis outbreak stemming from tainted spinal steroids that killed more than 60 people and sickened hundreds more. The legal fallout from drugs produced at the New England Compounding Center’s Framingham, Massachusetts, facility has been described as the biggest criminal case ever brought in the U.S. over contaminated medicine.

The industry is still subject to ongoing regulatory updates compounding pharmacies must monitor, including changes in the U.S. Food and Drug Administration inspection...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.